# A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

> **NCT00370513** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **DRUG:** pazopanib

## Key facts

- **NCT ID:** NCT00370513
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12-06
- **Primary completion:** 2009-04-08
- **Final completion:** 2009-04-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00370513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00370513, "A Phase I Study of Pazopanib in Adult Patients With Liver Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00370513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*